We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves First-in-Class Treatment for Redness Linked to Rosacea
FDA Approves First-in-Class Treatment for Redness Linked to Rosacea
August 27, 2013
Galderma’s rosacea portfolio just got bigger following FDA approval Monday of its topical gel Mirvaso, indicated to treat the signature redness associated with the inflammatory skin condition.